Fractyl Health (NASDAQ:GUTS) Trading 0.7% Higher

Fractyl Health, Inc. (NASDAQ:GUTS)’s stock price rose 0.7% during mid-day trading on Thursday . The company traded as high as $4.70 and last traded at $4.47. Approximately 101,767 shares changed hands during mid-day trading, a decline of 57% from the average daily volume of 237,115 shares. The stock had previously closed at $4.44.

Fractyl Health Stock Up 0.7 %

The stock’s fifty day simple moving average is $6.10. The company has a quick ratio of 9.37, a current ratio of 9.38 and a debt-to-equity ratio of 0.34.

Fractyl Health (NASDAQ:GUTS) last posted its quarterly earnings results on Monday, May 13th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.30) by ($0.45). The business had revenue of $0.03 million during the quarter. Equities research analysts anticipate that Fractyl Health, Inc. will post -2.03 earnings per share for the current fiscal year.

Institutional Trading of Fractyl Health

An institutional investor recently bought a new position in Fractyl Health stock. American International Group Inc. bought a new position in shares of Fractyl Health, Inc. (NASDAQ:GUTS) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 1,339,261 shares of the company’s stock, valued at approximately $9,911,000. American International Group Inc. owned about 2.80% of Fractyl Health as of its most recent filing with the Securities and Exchange Commission (SEC).

About Fractyl Health

Fractyl Health, Inc, a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.